Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 48.45 Delayed Data As of Apr 12 |  -0.27 / -0.55%Today’s Change | 40.32 Today|||52-Week Range 58.59 | +15.08% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 160.9M | 88.3M | 102.8M | 206.6M | |
| Depreciation And Amortization | 639.0K | 1.7M | 2.1M | 2.5M | ||
| Operating Expenses | Gross Income | -- | -- | -- | -- | -- |
| General Expenses | 36.1M | 55.8M | 76.1M | 115.8M | ||
| Research And Development | 23.2M | 40.5M | 57.5M | 94.9M | ||
| Total Operating Expenses | 36.7M | 57.4M | 78.2M | 118.3M | ||
| Non-Operating Expenses | Operating Income | 124.1M | 30.8M | 24.6M | 88.3M | |
| Extraordinary Credit | 347.0K | 29.0K | 0.00 | 0.00 | ||
| Extraordinary Charge | 0.00 | 0.00 | -159.0K | -59.0K | ||
| Interest Expense On Debt | 8.0K | 45.0K | 40.0K | -- | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 125.5M | 32.6M | 26.9M | 93.1M | |
| Income Taxes | -46.5M | -10.9M | -9.2M | -21.2M | ||
| Net Income | 79.0M | 21.7M | 17.7M | 72.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 18.7M | 18.9M | 19.1M | 19.3M | |
| Shares To Calculate EPS Diluted | 19.3M | 19.2M | 19.4M | 20.7M | ||
| Earnings Per Share | EPS | $4.09 | $1.13 | $0.91 | $3.48 | |
| EPS Diluted | $4.09 | $1.13 | $0.91 | $3.48 | ||
